In a preclinical study, UC Davis Comprehensive Cancer Center scientists developed a highly targeted gene therapy that could revolutionize treatment for cancers linked to a common herpesvirus, with minimal side effects.
The novel approach…
Genetic “Trojan horse” selectively kills cancer cells linked to Kaposi’s sarcoma
